pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Marketed
    lamivudine
    Epivir (lamivudine)
    Human Immunodeficiency Virus (HIV) Infections (AIDS) ViiV Healthcare Company
  • Marketed
    lanadelumab
    Takhzyro (lanadelumab-flyo)
    Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-IN… Takeda Pharmaceuticals USA Inc
  • Marketed
    landiolol hydrochloride
    Rapiblyk (landiolol hydrochloride)
    Atrial Fibrillation AOP Health
  • Marketed
← prev
page 189 of 231
next →
Pain89
Neurology1
lanreotide acetate PR
Somatuline Depot (lanreotide acetate)
Acromegaly
Ipsen Biopharmaceuticals Inc
  • Marketed
    lanthanum carbonate
    Lanthanum Carbonate
    Hyperphosphatemia In Chronic Kidney Disease Barr Laboratories Inc
  • Marketed
    lapatinib ditosylate
    Lapatinib (lapatinib ditosylate)
    Human Epidermal Growth Factor Receptor 2 Positive Breast… Lupin Ltd
  • Phase 2
    laromestrocel
    laromestrocel [INN]
    Alzheimer's Disease$LGVN Longeveron Inc.
  • Marketed
    laronidase
    Aldurazyme (laronidase)
    Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) Genzyme Corp
  • Marketed
    larotrectinib sulfate
    Larotrectinib Sulfate Bayer (larotrectinib sulfate)
    Solid Tumor Bayer HealthCare Pharmaceuticals Inc
  • Phase 3
    larsucosterol sodium
    larsucosterol sodium
    Alcoholic Hepatitis$BHC Bausch Health Companies Inc.
  • Phase 3
    laruparetigene zovaparvovec
    laruparetigene zovaparvovec
    Retinitis Pigmentosa (Retinitis) Beacon Therapeutics Ltd
  • Phase 2
    lasmecabtagene timgedleucel
    lasmecabtagene timgedleucel
    B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphobla… Cellectis SA
  • Marketed
    lasmiditan
    Reyvow (lasmiditan)
    Migraine Eli Lilly and Co
  • Phase 1
    lasmotinib
    lasmotinib [INN]
    Refractory Acute Myeloid Leukemia Pharos iBio Co Ltd
  • Phase 3
    lasofoxifene tartrate
    lasofoxifene tartrate
    Human Epidermal Growth Factor Receptor 2 Negative Breast…$LONA LeonaBio, Inc.
  • Marketed
    latanoprostene bunod
    Vyzulta (latanoprostene bunod)
    Ocular Hypertension$BLCO Bausch & Lomb Corp
  • Phase 3
    latarcibart
    latarcibart [INN]
    Von Willebrand Disease (vWD)$STHO Star Holdings
  • Phase 1
    lecomkafusp alfa
    lecomkafusp alfa [INN]
    Adenocarcinoma Of The Gastroesophageal Junction$HOWL Werewolf Therapeutics, Inc.
  • Marketed
    lefamulin acetate
    Xenleta (lefamulin acetate)
    Community-Acquired Bacterial Pneumonia Nabriva Therapeutics US Inc
  • Phase 1
    lefelsiran sodium
    lefelsiran sodium
    Alcohol Use Disorder (AUD) Novo Nordisk AS
  • Phase 1
    lefitolimod
    lefitolimod [INN]
    Solid Tumor Mologen AG
  • Marketed
    lemborexant
    Dayvigo (lemborexant)
    Insomnia Eisai Co Ltd
  • Phase 2
    lenacapavir + teropavimab + zinlirvimab
    lenacapavir + teropavimab + zinlirvimab
    Human Immunodeficiency Virus (HIV) Infections (AIDS)$GILD GILEAD SCIENCES, INC.
  • Phase 3
    lenadogene nolparvovec
    LUMEVOQ (lenadogene nolparvovec [INN])
    Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy) GenSight Biologics SA
  • Marketed
    leniolisib
    Joenja (leniolisib [INN])
    Common Variable Immunodeficiency (CVID) Pharming Group NV
  • Phase 3
    lepodisiran sodium
    lepodisiran sodium
    Atherosclerosis Eli Lilly and Co
  • Phase 2
    lepunafusp alfa
    lepunafusp alfa [INN]
    Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) JCR Pharmaceuticals Co Ltd
  • Phase 2
    lepzacitinib
    lepzacitinib
    Atopic Dermatitis (Atopic Eczema)$ACRS Aclaris Therapeutics, Inc.
  • Phase 2
    lerapolturev
    lerapolturev [INN]
    Metastatic Melanoma Istari Oncology Inc
  • Phase 2
    leronlimab
    leronlimab
    Metabolic Dysfunction-Associated Steatohepatitis (MASH or…$CYDY CytoDyn Inc.